{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:34:24Z","timestamp":1791819264115,"version":"4.3.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1K01DK116929-01A1"],"award-info":[{"award-number":["1K01DK116929-01A1"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-031690"],"award-info":[{"award-number":["INV-031690"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Low- and middle-income countries are facing a growing burden of noncommunicable diseases (NCDs). Providing HIV treatment may provide opportunities to increase access to NCD services in under-resourced environments. We conducted a systematic review and meta-analysis to evaluate whether use of antiretroviral therapy (ART) was associated with increased screening, diagnosis, treatment, and control of diabetes, hypertension, chronic kidney disease, or cardiovascular disease among people living with HIV in sub-Saharan Africa\u00a0(SSA). A comprehensive search of electronic literature databases for studies published between 01 January 2011 and 31 December 2022 yielded 26 studies, describing 13,570 PLWH in SSA, 61% of whom were receiving ART. Random effects models were used to calculate summary odds ratios (ORs) of the risk of diagnosis by ART status and corresponding 95% confidence intervals (95% CIs), where appropriate. ART use was associated with a small but imprecise increase in the odds of diabetes diagnosis (OR 1.07; 95% CI 0.71, 1.60) and an increase in the odds of hypertension diagnosis (OR 2.10, 95% CI 1.42, 3.09). We found minimal data on the association between ART use and screening, treatment, or control of NCDs. Despite a potentially higher NCD risk among PLWH and regional efforts to integrate NCD and HIV care, evidence to support effective care integration models is lacking.<\/jats:p>","DOI":"10.1007\/s10461-023-04248-0","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T09:02:25Z","timestamp":1706778145000},"page":"591-608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Does Engagement in HIV Care Affect Screening, Diagnosis, and Control of Noncommunicable Diseases in Sub-Saharan Africa? A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0557-2035","authenticated-orcid":false,"given":"Emma M.","family":"Kileel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Bor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya A.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyabonga","family":"Khoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem D. F.","family":"Venter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Raal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Hibberd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana T.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"4248_CR1","unstructured":"\u201cAbout Global NCDs|Division of Global Health Protection|. Global Health| CDC.\u201d\u00a0https:\/\/www.cdc.gov\/globalhealth\/healthprotection\/ncd\/global-ncd-overview.html.\u00a0Accessed 16 Nov 2022."},{"key":"4248_CR2","unstructured":"\u201cNoncommunicable diseases. now \u2018top killers globally\u2019 \u2013 UN health agency report | | 1UN News.\u201d\u00a0https:\/\/news.un.org\/en\/story\/2022\/09\/1127211.\u00a0Accessed 16 Nov 2022."},{"issue":"10","key":"4248_CR3","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/J.1365-3156.2008.02116.X","volume":"13","author":"JJ Miranda","year":"2008","unstructured":"Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health. 2008;13(10):1225. https:\/\/doi.org\/10.1111\/J.1365-3156.2008.02116.X.","journal-title":"Trop Med Int Health"},{"key":"4248_CR4","doi-asserted-by":"publisher","unstructured":"Kassa M, Grace J, Kassa M, Grace J. \u201cThe Global Burden and Perspectives on Non-Communicable Diseases (NCDs) and the Prevention, Data Availability and Systems Approach of NCDs in Low-resource Countries,\u201d Public Health in Developing Countries - Challenges and Opportunities, Nov. 2019, https:\/\/doi.org\/10.5772\/INTECHOPEN.89516.","DOI":"10.5772\/INTECHOPEN.89516"},{"issue":"1","key":"4248_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12916-015-0357-9\/TABLES\/7","volume":"13","author":"B Kavishe","year":"2015","unstructured":"Kavishe B, et al. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC Med. 2015;13(1):1\u201321. https:\/\/doi.org\/10.1186\/S12916-015-0357-9\/TABLES\/7.","journal-title":"BMC Med"},{"key":"4248_CR6","unstructured":"\u201cMortality and global health estimates\u201d.\u00a0https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates.\u00a0Accessed 12 Sep 2022."},{"issue":"4","key":"4248_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/IJE\/DYR050","volume":"40","author":"S Dalal","year":"2011","unstructured":"Dalal S, et al. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol. 2011;40(4):885\u2013901. https:\/\/doi.org\/10.1093\/IJE\/DYR050.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"4248_CR8","doi-asserted-by":"publisher","first-page":"e25012","DOI":"10.1002\/JIA2.25012","volume":"20","author":"A Van Heerden","year":"2017","unstructured":"Van Heerden A, Barnabas RV, Norris SA, Micklesfield LK, Van Rooyen H, Celum C. High prevalence of HIV and non-communicable disease (NCD) risk factors in rural KwaZulu-Natal, South Africa. J Int AIDS Soc. 2017;20(2):e25012. https:\/\/doi.org\/10.1002\/JIA2.25012.","journal-title":"J Int AIDS Soc"},{"key":"4248_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1477-7525-5-52","volume":"5","author":"M Fortin","year":"2007","unstructured":"Fortin M, Dubois MF, Hudon C, Soubhi H, Almirall J. Multimorbidity and quality of life: a closer look. Health Qual Life Outcomes. 2007;5:52. https:\/\/doi.org\/10.1186\/1477-7525-5-52.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"4248_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/FAMPRA\/CMT061","volume":"31","author":"HP Booth","year":"2014","unstructured":"Booth HP, Prevost AT, Gulliford MC. Impact of body mass index on prevalence of multimorbidity in primary care: cohort study. Fam Pract. 2014;31(1):38. https:\/\/doi.org\/10.1093\/FAMPRA\/CMT061.","journal-title":"Fam Pract"},{"issue":"10","key":"4248_CR11","doi-asserted-by":"publisher","first-page":"e25818","DOI":"10.1002\/JIA2.25818","volume":"24","author":"K Joshi","year":"2021","unstructured":"Joshi K, et al. Declining HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis of empiric data. J Int AIDS Soc. 2021;24(10):e25818. https:\/\/doi.org\/10.1002\/JIA2.25818.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"4248_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13473-y","volume":"10","author":"A Vandormael","year":"2019","unstructured":"Vandormael A, Akullian A, Siedner M, de Oliveira T, B\u00e4rnighausen T, Tanser F. Declines in HIV incidence among men and women in a South African population-based cohort. Nat Commun. 2019;10(1):1\u201310. https:\/\/doi.org\/10.1038\/s41467-019-13473-y.","journal-title":"Nat Commun"},{"issue":"5","key":"4248_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/QAD.0000000000000103","volume":"28","author":"JC Yombi","year":"2014","unstructured":"Yombi JC, et al. Antiretrovirals and the kidney in current clinical practice: Renal pharmacokinetics, alterations of renal function and renal toxicity. AIDS. 2014;28(5):621\u201332. https:\/\/doi.org\/10.1097\/QAD.0000000000000103.","journal-title":"AIDS"},{"issue":"11","key":"4248_CR14","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/CID\/CIAB552","volume":"73","author":"PS Douglas","year":"2021","unstructured":"Douglas PS, et al. Cardiovascular risk and health among people with human immunodeficiency virus (HIV) eligible for primary prevention: insights from the REPRIEVE trial. Clin Infect Dis. 2021;73(11):2009\u201322. https:\/\/doi.org\/10.1093\/CID\/CIAB552.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4248_CR15","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/CID\/CIZ999","volume":"71","author":"PE Sax","year":"2020","unstructured":"Sax PE, et al. Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials. Clin Infect Dis. 2020;71(6):1379. https:\/\/doi.org\/10.1093\/CID\/CIZ999.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4248_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/QAI.0000000000001525","volume":"76","author":"J Norwood","year":"2017","unstructured":"Norwood J, et al. Weight gain in persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens. J Acquir Immune Defic Syndr. 2017;76(5):527. https:\/\/doi.org\/10.1097\/QAI.0000000000001525.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4248_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/OFID\/OFAB537","author":"EM Kileel","year":"2021","unstructured":"Kileel EM, et al. Assessment of obesity and cardiometabolic status by integrase inhibitor use in reprieve: a propensity-weighted analysis of a multinational primary cardiovascular prevention cohort of people with human immunodeficiency virus. Open Forum Infect Dis. 2021. https:\/\/doi.org\/10.1093\/OFID\/OFAB537.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"4248_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/J.GHEART.2016.01.003","volume":"11","author":"SA Patel","year":"2016","unstructured":"Patel SA, et al. Obesity and its relation with diabetes and hypertension: a cross-sectional study across four low- and middle-income country regions. Glob Heart. 2016;11(1):71. https:\/\/doi.org\/10.1016\/J.GHEART.2016.01.003.","journal-title":"Glob Heart"},{"issue":"3 Pt 2","key":"4248_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/01.HYP.38.3.705","volume":"38","author":"MT Zanella","year":"2001","unstructured":"Zanella MT, Kohlmann O, Ribeiro AB. Treatment of obesity hypertension and diabetes syndrome. Hypertension. 2001;38(3 Pt 2):705\u20138. https:\/\/doi.org\/10.1161\/01.HYP.38.3.705.","journal-title":"Hypertension"},{"key":"4248_CR20","doi-asserted-by":"publisher","first-page":"102388","DOI":"10.1016\/J.JHEALECO.2020.102388","volume":"75","author":"A Ciancio","year":"2021","unstructured":"Ciancio A, K\u00e4mpfen F, Kohler HP, Kohler IV. Health screening for emerging non-communicable disease burdens among the global poor: evidence from sub-Saharan Africa. J Health Econ. 2021;75:102388. https:\/\/doi.org\/10.1016\/J.JHEALECO.2020.102388.","journal-title":"J Health Econ"},{"issue":"5","key":"4248_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/QAI.0000000000001445","volume":"75","author":"J Manne-Goehler","year":"2017","unstructured":"Manne-Goehler J, et al. The ART advantage: health care utilization for diabetes and hypertension in rural South Africa. J Acquir Immune Defic Syndr. 2017;75(5):561\u20137. https:\/\/doi.org\/10.1097\/QAI.0000000000001445.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4248_CR22","unstructured":"Republic of Zambia Ministry of Health. \u201cZambia Consolidated Guidelines for Treatment and Prevention of HIV Infection.\u201d\u00a0https:\/\/www.moh.gov.zm\/wp-content\/uploads\/filebase\/Zambia-Consolidated-Guidelines-for-Treatment-and-Prevention-of-HIV-Infection-2020.pdf.\u00a0Accessed 23 Jan 2023."},{"key":"4248_CR23","unstructured":"Department of Health of the Republic of South Africa. \u201c2019 ART Clinical Guidelines for the Management of HIV in Adults, Pregnancy, Adolescents, Children, Infants and Neonates.\u201d https:\/\/www.health.gov.za\/wp-content\/uploads\/2020\/11\/2019-art-guideline.pdf.\u00a0Accessed 23 Jan 2023."},{"key":"4248_CR24","unstructured":"Ministry of Health and Population of Malawi. \u201cClinical Management of HIV in Children and Adults.\u201d\u00a0https:\/\/differentiatedservicedelivery.org\/wp-content\/uploads\/malawi-clinical-hiv-guidelines-2018-1.pdf.\u00a0Accessed 23 Jan 2023."},{"key":"4248_CR25","unstructured":"UNAIDS.\u00a0\u201dLatest global and regional statistics on the status of the AIDS epidemic\u201d, 2022."},{"issue":"542","key":"4248_CR26","first-page":"759","volume":"57","author":"A Sayers","year":"2007","unstructured":"Sayers A. Tips and tricks in performing a systematic review. British J Gen Pract. 2007;57(542):759.","journal-title":"British J Gen Pract"},{"key":"4248_CR27","unstructured":"\u201cCovidence - Better systematic review management.\u201d\u00a0https:\/\/www.covidence.org\/.\u00a0Accessed 13 Sep 2022."},{"key":"4248_CR28","unstructured":"\u201cCritical Appraisal Tools | JBI. \u201d\u00a0https:\/\/jbi.global\/critical-appraisal-tools.\u00a0Accessed 16 Nov 2022."},{"key":"4248_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318221863f","author":"JA Dave","year":"2011","unstructured":"Dave JA, Lambert EV, Badri M, West S, Maartens G, Levitt NS. Effect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in south African HIV-infected patients. J Acquir Immune Defic Syndr. 2011. https:\/\/doi.org\/10.1097\/QAI.0b013e318221863f.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"4248_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/0300-1652.114591","volume":"54","author":"M Sani","year":"2013","unstructured":"Sani M, Okeahialam B, Muhammad S. Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy. Nigerian Med J. 2013;54(3):185. https:\/\/doi.org\/10.4103\/0300-1652.114591.","journal-title":"Nigerian Med J"},{"key":"4248_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0125-2","author":"RN Peck","year":"2014","unstructured":"Peck RN, et al. Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Med. 2014. https:\/\/doi.org\/10.1186\/s12916-014-0125-2.","journal-title":"BMC Med"},{"key":"4248_CR32","doi-asserted-by":"publisher","DOI":"10.2174\/1874613601509010051","author":"D Shey Nsagha","year":"2015","unstructured":"Shey Nsagha D, et al. Risk factors of cardiovascular diseases in HIV\/AIDS patients on HAART. Open AIDS J. 2015. https:\/\/doi.org\/10.2174\/1874613601509010051.","journal-title":"Open AIDS J"},{"key":"4248_CR33","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2016.23.206.7041","author":"D Osegbe","year":"2016","unstructured":"Osegbe D, Soriyan OO, Ogbenna AA, Okpara HC, Azinge EC. Risk factors and assessment for cardiovascular disease among HIV-positive patients attending a nigerian tertiary hospital. Pan African Med J. 2016. https:\/\/doi.org\/10.11604\/pamj.2016.23.206.7041.","journal-title":"Pan African Med J"},{"issue":"1","key":"4248_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3916-x","volume":"16","author":"OH Divala","year":"2016","unstructured":"Divala OH, et al. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services. BMC Public Health. 2016;16(1):1\u201311. https:\/\/doi.org\/10.1186\/s12889-016-3916-x.","journal-title":"BMC Public Health"},{"issue":"15","key":"4248_CR35","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/heartjnl-2015-309026","volume":"102","author":"R Kingery","year":"2016","unstructured":"Kingery R, et al. Short-term and long-term cardiovascular risk, metabolic syndrome and HIV in Tanzania. Heart. 2016;102(15):1200\u20135. https:\/\/doi.org\/10.1136\/heartjnl-2015-309026.","journal-title":"Heart"},{"issue":"6","key":"4248_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/apc.2018.0052","volume":"32","author":"A Osoti","year":"2018","unstructured":"Osoti A, et al. Metabolic syndrome among antiretroviral therapy-naive versus experienced HIV-infected patients without preexisting cardiometabolic disorders in western Kenya. AIDS Patient Care STDS. 2018;32(6):215\u201322. https:\/\/doi.org\/10.1089\/apc.2018.0052.","journal-title":"AIDS Patient Care STDS"},{"key":"4248_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-6716-2","author":"D Achwoka","year":"2019","unstructured":"Achwoka D, et al. Noncommunicable disease burden among HIV patients in care: a national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003\u20132013. BMC Public Health. 2019. https:\/\/doi.org\/10.1186\/s12889-019-6716-2.","journal-title":"BMC Public Health"},{"key":"4248_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25213\/full","author":"J Manne-Goehler","year":"2019","unstructured":"Manne-Goehler J, et al. Hypertension and diabetes control along the HIV care cascade in rural South Africa. J Int Aids Soc. 2019. https:\/\/doi.org\/10.1002\/jia2.25213\/full.","journal-title":"J Int Aids Soc"},{"key":"4248_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jns.2018.12.026","volume":"397","author":"FS Sarfo","year":"2019","unstructured":"Sarfo FS, et al. Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana. J Neurol Sci. 2019;397:103\u201311. https:\/\/doi.org\/10.1016\/j.jns.2018.12.026.","journal-title":"J Neurol Sci"},{"key":"4248_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230723","author":"K Jeremiah","year":"2020","unstructured":"Jeremiah K, et al. Diabetes prevalence by HbA1c and oral glucose tolerance test among HIV-infected and uninfected Tanzanian adults. PLoS ONE. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0230723.","journal-title":"PLoS ONE"},{"issue":"4","key":"4248_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/hiv.13007","volume":"22","author":"FS Sarfo","year":"2021","unstructured":"Sarfo FS, et al. Prevalence and incidence of pre-diabetes and diabetes mellitus among people living with HIV in Ghana: Evidence from the EVERLAST Study. HIV Med. 2021;22(4):231\u201343. https:\/\/doi.org\/10.1111\/hiv.13007.","journal-title":"HIV Med"},{"key":"4248_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244742","author":"GVT Roozen","year":"2021","unstructured":"Roozen GVT, et al. Electrocardiographic and echocardiographic abnormalities in urban African people living with HIV in South Africa. PLoS ONE. 2021. https:\/\/doi.org\/10.1371\/journal.pone.0244742.","journal-title":"PLoS ONE"},{"key":"4248_CR43","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2147\/HIV.S304982","volume":"13","author":"T Msoka","year":"2021","unstructured":"Msoka T, et al. Comparison of predicted cardiovascular risk profiles by different CVD risk-scoring algorithms between HIV-1-infected and uninfected adults: a cross-sectional study in Tanzania. HIV\/AIDS\u2014Res Palliative Care. 2021;13:605\u201315. https:\/\/doi.org\/10.2147\/HIV.S304982.","journal-title":"HIV\/AIDS\u2014Res Palliative Care"},{"issue":"1","key":"4248_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.diabet.2012.08.012","volume":"39","author":"G Ekali","year":"2013","unstructured":"Ekali G, et al. Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment. Diabetes Metab. 2013;39(1):71\u20137. https:\/\/doi.org\/10.1016\/j.diabet.2012.08.012.","journal-title":"Diabetes Metab"},{"issue":"2","key":"4248_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.hlc.2013.07.019","volume":"23","author":"S Botha","year":"2014","unstructured":"Botha S, Fourie CMT, van Rooyen JM, Kruger A, Schutte AE. Cardiometabolic changes in treated versus never treated HIV-infected black south Africans: the PURE study. Heart Lung Circ. 2014;23(2):119\u201326. https:\/\/doi.org\/10.1016\/j.hlc.2013.07.019.","journal-title":"Heart Lung Circ"},{"key":"4248_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/VHRM.S58449","volume":"10","author":"J Ogunmola","year":"2014","unstructured":"Ogunmola J, Oladosu OY, Olamoyegun AM. Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: a cross-sectional cohort study. Vasc Health Risk Manag. 2014;10:129\u201337. https:\/\/doi.org\/10.2147\/VHRM.S58449.","journal-title":"Vasc Health Risk Manag"},{"issue":"4","key":"4248_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/1596-3519.152072","volume":"14","author":"OJ Ogunmola","year":"2015","unstructured":"Ogunmola OJ, Oladosu YO, Olamoyegun MA. QTC interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs. Ann Afr Med. 2015;14(4):169. https:\/\/doi.org\/10.4103\/1596-3519.152072.","journal-title":"Ann Afr Med"},{"key":"4248_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148100","author":"CA Dimala","year":"2016","unstructured":"Dimala CA, Atashili J, Mbuagbaw JC, Wilfred A, Monekosso GL. Prevalence of hypertension in HIV\/AIDS patients on highly active antiretroviral therapy (HAART) compared with HAART-na\u00efve patients at the Limbe Regional Hospital, Cameroon. PLoS ONE. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0148100.","journal-title":"PLoS ONE"},{"key":"4248_CR49","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ijcard.2016.06.210","volume":"220","author":"CU Nduka","year":"2016","unstructured":"Nduka CU, et al. A plausible causal link between antiretroviral therapy and increased blood pressure in a sub-Saharan African setting: a propensity score-matched analysis. Int J Cardiol. 2016;220:400\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.210.","journal-title":"Int J Cardiol"},{"key":"4248_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-12-40","author":"J Cailhol","year":"2011","unstructured":"Cailhol J, et al. Prevalence of chronic kidney disease among people living with HIV\/AIDS in Burundi: a cross-sectional study. BMC Nephrol. 2011. https:\/\/doi.org\/10.1186\/1471-2369-12-40.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4248_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jinf.2013.03.008","volume":"67","author":"FS Sarfo","year":"2013","unstructured":"Sarfo FS, et al. High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians. J Infect. 2013;67(1):43\u201350. https:\/\/doi.org\/10.1016\/j.jinf.2013.03.008.","journal-title":"J Infect"},{"issue":"6","key":"4248_CR52","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1177\/0956462420901985","volume":"31","author":"A Che Awah Nforbugwe","year":"2020","unstructured":"Che Awah Nforbugwe A, Acha Asongalem E, Bihnwi Nchotu R, Asangbeng Tanue E, Sevidzem Wirsiy F, Nguedia Assob JC. Prevalence of renal dysfunction and associated risk factors among HIV patients on ART at the Bamenda Regional Hospital, Cameroon. Int J STD AIDS. 2020;31(6):526\u201332. https:\/\/doi.org\/10.1177\/0956462420901985.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"4248_CR53","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/1319-2442.367828","volume":"33","author":"MM Sulaiman","year":"2022","unstructured":"Sulaiman MM, et al. Comparative evaluation of prevalence, risk factors, and pathologic features of kidney disease in highly active antiretroviral therapy-naive and highly active antiretroviral therapy-experienced patients at a tertiary health facility in Maiduguri, Northeastern Nigeria. Saudi J Kidney Dis Transpl. 2022;33(1):72\u20139. https:\/\/doi.org\/10.4103\/1319-2442.367828.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"3","key":"4248_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"key":"4248_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.D4002","author":"JAC Sterne","year":"2011","unstructured":"Sterne JAC, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011. https:\/\/doi.org\/10.1136\/BMJ.D4002.","journal-title":"BMJ"},{"key":"4248_CR56","unstructured":"World Health Organization, \"Follow-up to the political declaration of the high-level meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases\u201d."},{"key":"4248_CR57","unstructured":"UNAIDS., \u201cChronic care of HIV and noncommunicable diseases: How to leverage the HIV experience.\u201d\u00a0https:\/\/www.unaids.org\/en\/resources\/documents\/2011\/20110526_JC2145_Chronic_care_of_HIV. Accessed 23 Jan 2023."},{"key":"4248_CR58","volume-title":"Global actionplan for the prevention and control of noncommunicable diseases 2013\u20132020","author":"WHO","year":"2013","unstructured":"WHO. Global actionplan for the prevention and control of noncommunicable diseases 2013\u20132020. Russia: WorldHealth Organization; 2013."},{"issue":"1","key":"4248_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12913-019-4785-7\/FIGURES\/4","volume":"19","author":"L Lebina","year":"2019","unstructured":"Lebina L, et al. Process evaluation of implementation fidelity of the integrated chronic disease management model in two districts, South Africa. BMC Health Serv Res. 2019;19(1):1\u201314. https:\/\/doi.org\/10.1186\/S12913-019-4785-7\/FIGURES\/4.","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"4248_CR60","doi-asserted-by":"publisher","first-page":"e0166375","DOI":"10.1371\/JOURNAL.PONE.0166375","volume":"11","author":"C Angkurawaranon","year":"2016","unstructured":"Angkurawaranon C, Nitsch D, Larke N, Rehman AM, Smeeth L, Addo J. Ecological study of HIV infection and hypertension in sub-Saharan Africa: is there a double burden of disease? PLoS ONE. 2016;11(11):e0166375. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0166375.","journal-title":"PLoS ONE"},{"issue":"6","key":"4248_CR61","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/JHH.2015.97","volume":"30","author":"CU Nduka","year":"2016","unstructured":"Nduka CU, Stranges S, Sarki AM, Kimani PK, Uthman OA. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis. J Hum Hypertens. 2016;30(6):355\u201362. https:\/\/doi.org\/10.1038\/JHH.2015.97.","journal-title":"J Hum Hypertens"},{"key":"4248_CR62","doi-asserted-by":"publisher","DOI":"10.5414\/CNP83S032","author":"S Naicker","year":"2015","unstructured":"Naicker S, Rahmanian S, Kopp JB. HIV and chronic Kidney Disease. Clin Nephrol. 2015. https:\/\/doi.org\/10.5414\/CNP83S032.","journal-title":"Clin Nephrol"},{"issue":"4Suppl 3","key":"4248_CR63","doi-asserted-by":"publisher","first-page":"19513","DOI":"10.7448\/IAS.17.4.19513","volume":"17","author":"F Post","year":"2014","unstructured":"Post F. Adverse events: ART and the kidney: alterations in renal function and renal toxicity. J Int AIDS Soc. 2014;17(4Suppl 3):19513. https:\/\/doi.org\/10.7448\/IAS.17.4.19513.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"4248_CR64","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/J.ACKD.2009.07.009","volume":"17","author":"J Jao","year":"2010","unstructured":"Jao J, Wyatt CM. Antiretroviral medications: adverse effects on the kidney. Adv Chronic Kidney Dis. 2010;17(1):72\u201382. https:\/\/doi.org\/10.1053\/J.ACKD.2009.07.009.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"4248_CR65","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/J.PCAD.2016.02.008","volume":"58","author":"F Ballocca","year":"2016","unstructured":"Ballocca F, et al. HIV infection and primary prevention of cardiovascular disease: lights and shadows in the HAART era. Prog Cardiovasc Dis. 2016;58(5):565\u201376. https:\/\/doi.org\/10.1016\/J.PCAD.2016.02.008.","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"4248_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I 2 Index? Psychol Methods. 2006;11(2):193\u2013206. https:\/\/doi.org\/10.1037\/1082-989X.11.2.193.","journal-title":"Psychol Methods"},{"issue":"2","key":"4248_CR67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/JRSM.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97\u2013111. https:\/\/doi.org\/10.1002\/JRSM.12.","journal-title":"Res Synth Methods"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-023-04248-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-023-04248-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-023-04248-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T05:40:23Z","timestamp":1708321223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-023-04248-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["4248"],"URL":"https:\/\/doi.org\/10.1007\/s10461-023-04248-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.01.30.23285196","asserted-by":"object"}]},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"2 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases 1K01DK116929-01A1 (ATB and EMK) and the Bill & Melinda Gates Foundation INV-031690 (SR). For the remaining authors none were declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}